Person · CIK 1666236

Steve E. Krognes

Director at Guardant Health and Pliant Therapeutics; CFO and Treasurer at Denali Therapeutics

Earlier: Gritstone bio and Corvus Pharmaceuticals

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$17.6M

Noticed on Form 144$6.7M

Bought on Form 4$0

Companies5

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Guardant Health GH	Common Stock	Directly	7,906	Sep 16, 2026 · Filing · EDGAR
Pliant Therapeutics PLRX	Stock Option (Right to Buy) exercise $1.14, expires Jun 11, 2036, into Common Stock	Directly	70,000	Jun 11, 2026 · Filing · EDGAR
Denali Therapeutics DNLI	Common Stock	Directly	38,202	Jun 3, 2026 · Filing · EDGAR
Denali Therapeutics DNLI	Common Stock	See footnote	781,797	Jun 3, 2026 · Filing · EDGAR
Denali Therapeutics DNLI	Stock Option (right to buy) exercise $19.66, expires Jun 3, 2036, into Common Stock	Directly	19,226	Jun 3, 2026 · Filing · EDGAR
Gritstone bio	Stock Option (Right to Buy) exercise $2.19, expires Jun 15, 2033, into Common Stock	Directly	51,800	Jun 16, 2023 · Filing · EDGAR
Corvus Pharmaceuticals	Stock Option (Right to Buy) exercise $3.27, expires Jun 9, 2030, into Common Stock	Directly	15,000	Jun 9, 2020 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q3 2026	$1.2M	$1.2M
Q2 2026	$1.2M	$1.2M
Q1 2025	$69K	$69K
Q4 2024	$608K	$607K
Q3 2024	$1.6M	$1.6M
Q2 2024	$1.9M	$1.9M
Q1 2024	$110K	$110K
Q3 2023	$32K	$32K
Q1 2023	$191K	Not machine-readable
Q3 2022	$75K	Not machine-readable
Q1 2022	$236K	Not machine-readable
Q3 2021	$113K	Not machine-readable
Q1 2021	$10.2M	Not machine-readable
Q1 2020	$28K	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Guardant Health GH · Charles Schwab · No 10b5-1 plan stated · 2 notices
Sep 16, 2026	6,674 · ~$1.2M	Sep 16, 2026	Sold as noticed Sold 6,674 in 4 sales, Sep 16 to Sep 16 · $1.2M Form 4	Filing · EDGAR
Jun 4, 2026	9,294 · ~$1.2M	Jun 4, 2026	Sold as noticed Sold 9,294 at $132.51 on Jun 4 · $1.2M Form 4	Filing · EDGAR
Denali Therapeutics DNLI · Morgan Stanley Smith Barney · No 10b5-1 plan stated · 4 notices
Jan 7, 2025	3,339 · ~$69K	Jan 7, 2025	Sold as noticed Sold 3,339 at $20.81 on Jan 7 · $69K Form 4	Filing · EDGAR
Aug 20, 2024	1,727 · ~$41K	Aug 20, 2024	Sold as noticed Sold 1,727 at $23.79 on Aug 20 · $41K Form 4	Filing · EDGAR
Feb 13, 2024	2,750 · ~$48K	Feb 13, 2024	Sold as noticed Sold 2,750 at $17.29 on Feb 13 · $48K Form 4	Filing · EDGAR
Jan 5, 2024	3,208 · ~$62K	Jan 5, 2024	Sold as noticed Sold 3,208 at $19.43 on Jan 5 · $62K Form 4	Filing · EDGAR
Denali Therapeutics DNLI · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 1, 2023 · 4 notices
Dec 31, 2024	30,000 · ~$607K	Dec 31, 2024	Sold as noticed Sold 30,000 at $20.25 on Dec 31 · $608K Form 4	Filing · EDGAR
Sep 30, 2024	30,000 · ~$883K	Sep 30, 2024	Sold as noticed Sold 30,000 at $29.03 on Sep 30 · $871K Form 4	Filing · EDGAR
Jul 1, 2024	30,000 · ~$697K	Jul 1, 2024	Sold as noticed Sold 30,000 in 2 sales, Jul 1 to Jul 1 · $664K Form 4	Filing · EDGAR
Apr 1, 2024	92,500 · ~$1.9M	Apr 1, 2024	Sold as noticed Sold 93,188 in 2 sales, Apr 1 to Jun 13 · $1.9M Form 4 (1) · Form 4 (2)	Filing · EDGAR
Denali Therapeutics DNLI · Charles Schwab · No 10b5-1 plan stated · 1 notice
Aug 21, 2023	1,419 · ~$32K	Aug 21, 2023	Sold as noticed Sold 1,419 at $22.60 on Aug 21 · $32K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 26 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,119 at $30.10 on Feb 13, 2023 · $64K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,377 at $30.88 on Feb 8, 2023 · $43K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,970 at $28.44 on Jan 5, 2023 · $84K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,253 at $33.22 on Aug 19, 2022 · $75K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,560 at $34.69 on Feb 11, 2022 · $89K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,296 at $37.09 on Feb 9, 2022 · $48K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,225 at $44.75 on Jan 5, 2022 · $100K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 200 at $50.07 on Aug 19, 2021 · $10K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,085 at $49.52 on Aug 19, 2021 · $103K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,158 at $63.67 on Mar 15, 2021 · $74K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 3,258 at $62.71 on Mar 15, 2021 · $204K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 32,326 at $62.04 on Mar 15, 2021 · $2M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 13,258 at $61.16 on Mar 15, 2021 · $811K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 501 at $66.80 on Feb 16, 2021 · $33K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 16,616 at $66.20 on Feb 16, 2021 · $1.1M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 10,199 at $65.04 on Feb 16, 2021 · $663K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 22,684 at $64.27 on Feb 16, 2021 · $1.5M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 400 at $71.43 on Feb 11, 2021 · $29K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,635 at $70.17 on Feb 11, 2021 · $185K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 426 at $75.39 on Feb 9, 2021 · $32K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,022 at $74.38 on Feb 9, 2021 · $76K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 14,147 at $73.01 on Jan 15, 2021 · $1M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 8,071 at $71.99 on Jan 15, 2021 · $581K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 12,981 at $70.96 on Jan 15, 2021 · $921K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 14,801 at $70.10 on Jan 15, 2021 · $1M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,428 at $19.48 on Mar 30, 2020 · $28K	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Guardant Health GH Director · filings 2022 to 2026 · sold $2.4M · $2.4M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Sep 16, 2026	Open-market or private sale	−1,103	$174.46	$192K	13,477 direct	Filing · EDGAR
Sep 16, 2026	Open-market or private sale	−3,300	$175.42	$579K	10,177 direct	Filing · EDGAR
Sep 16, 2026	Open-market or private sale	−1,300	$176.34	$229K	8,877 direct	Filing · EDGAR
Sep 16, 2026	Open-market or private sale	−971	$177.48	$172K	7,906 direct	Filing · EDGAR
Jun 30, 2026	Option or RSU exercised or converted	+155			14,580 direct	Filing · EDGAR
Jun 30, 2026	Option or RSU exercised or converted Restricted Stock Units	−155			0 direct	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted	+4,203			14,425 direct	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted Restricted Stock Units	−4,203			0 direct	Filing · EDGAR
Jun 17, 2026	Grant or award from the company Restricted Stock Units	+2,711			2,711 direct	Filing · EDGAR
Jun 4, 2026	Open-market or private sale	−9,294	$132.51	$1.2M	10,222 direct	Filing · EDGAR
May 31, 2026	Option or RSU exercised or converted	+154			19,516 direct	Filing · EDGAR
May 31, 2026	Option or RSU exercised or converted Restricted Stock Units	−154			155 direct	Filing · EDGAR
Apr 30, 2026	Option or RSU exercised or converted	+154			19,362 direct	Filing · EDGAR
Apr 30, 2026	Option or RSU exercised or converted Restricted Stock Units	−154			309 direct	Filing · EDGAR
Mar 31, 2026	Option or RSU exercised or converted	+155			19,208 direct	Filing · EDGAR
Mar 31, 2026	Option or RSU exercised or converted Restricted Stock Units	−155			463 direct	Filing · EDGAR
Feb 28, 2026	Option or RSU exercised or converted	+154			19,053 direct	Filing · EDGAR
Feb 28, 2026	Option or RSU exercised or converted Restricted Stock Units	−154			618 direct	Filing · EDGAR
Jan 31, 2026	Option or RSU exercised or converted	+154			18,899 direct	Filing · EDGAR
Jan 31, 2026	Option or RSU exercised or converted Restricted Stock Units	−154			772 direct	Filing · EDGAR
Dec 31, 2025	Option or RSU exercised or converted	+154			18,745 direct	Filing · EDGAR
Dec 31, 2025	Option or RSU exercised or converted Restricted Stock Units	−154			926 direct	Filing · EDGAR
Nov 30, 2025	Option or RSU exercised or converted	+155			18,591 direct	Filing · EDGAR
Nov 30, 2025	Option or RSU exercised or converted Restricted Stock Units	−155			1,080 direct	Filing · EDGAR
Oct 31, 2025	Option or RSU exercised or converted	+154			18,436 direct	Filing · EDGAR
Oct 31, 2025	Option or RSU exercised or converted Restricted Stock Units	−154			1,235 direct	Filing · EDGAR
Sep 30, 2025	Option or RSU exercised or converted	+154			18,282 direct	Filing · EDGAR
Sep 30, 2025	Option or RSU exercised or converted Restricted Stock Units	−154			1,389 direct	Filing · EDGAR
Aug 31, 2025	Option or RSU exercised or converted	+155			18,128 direct	Filing · EDGAR
Aug 31, 2025	Option or RSU exercised or converted Restricted Stock Units	−155			1,543 direct	Filing · EDGAR
Jul 31, 2025	Option or RSU exercised or converted	+154			17,973 direct	Filing · EDGAR
Jul 31, 2025	Option or RSU exercised or converted Restricted Stock Units	−154			1,698 direct	Filing · EDGAR
Jun 30, 2025	Option or RSU exercised or converted	+154			17,819 direct	Filing · EDGAR
Jun 30, 2025	Option or RSU exercised or converted Restricted Stock Units	−154			1,852 direct	Filing · EDGAR
Jun 18, 2025	Grant or award from the company Stock Option (Right to Buy)	+6,833			6,833 direct	Filing · EDGAR
Jun 18, 2025	Grant or award from the company Restricted Stock Units	+4,203			4,203 direct	Filing · EDGAR
Jun 12, 2025	Option or RSU exercised or converted	+6,674			17,665 direct	Filing · EDGAR
Jun 12, 2025	Option or RSU exercised or converted Restricted Stock Units	−6,674			0 direct	Filing · EDGAR
May 31, 2025	Option or RSU exercised or converted	+154			10,991 direct	Filing · EDGAR
May 31, 2025	Option or RSU exercised or converted Restricted Stock Units	−154			2,006 direct	Filing · EDGAR
Apr 30, 2025	Option or RSU exercised or converted	+155			10,837 direct	Filing · EDGAR
Apr 30, 2025	Option or RSU exercised or converted Restricted Stock Units	−155			2,160 direct	Filing · EDGAR
Mar 31, 2025	Option or RSU exercised or converted	+154			10,682 direct	Filing · EDGAR
Mar 31, 2025	Option or RSU exercised or converted Restricted Stock Units	−154			2,315 direct	Filing · EDGAR
Feb 28, 2025	Option or RSU exercised or converted	+154			10,528 direct	Filing · EDGAR
Feb 28, 2025	Option or RSU exercised or converted Restricted Stock Units	−154			2,469 direct	Filing · EDGAR
Jan 31, 2025	Option or RSU exercised or converted	+154			10,374 direct	Filing · EDGAR
Jan 31, 2025	Option or RSU exercised or converted Restricted Stock Units	−154			2,623 direct	Filing · EDGAR
Dec 31, 2024	Option or RSU exercised or converted	+155			10,220 direct	Filing · EDGAR
Dec 31, 2024	Option or RSU exercised or converted Restricted Stock Units	−155			2,777 direct	Filing · EDGAR
Nov 30, 2024	Option or RSU exercised or converted	+154			10,065 direct	Filing · EDGAR
Nov 30, 2024	Option or RSU exercised or converted Restricted Stock Units	−154			2,932 direct	Filing · EDGAR
Oct 31, 2024	Option or RSU exercised or converted	+154			9,911 direct	Filing · EDGAR
Oct 31, 2024	Option or RSU exercised or converted Restricted Stock Units	−154			3,086 direct	Filing · EDGAR
Sep 30, 2024	Option or RSU exercised or converted	+154			9,757 direct	Filing · EDGAR
Sep 30, 2024	Option or RSU exercised or converted Restricted Stock Units	−154			3,240 direct	Filing · EDGAR
Aug 31, 2024	Option or RSU exercised or converted	+155			9,603 direct	Filing · EDGAR
Aug 31, 2024	Option or RSU exercised or converted Restricted Stock Units	−155			3,394 direct	Filing · EDGAR
Jul 31, 2024	Option or RSU exercised or converted	+154			9,448 direct	Filing · EDGAR
Jul 31, 2024	Option or RSU exercised or converted Restricted Stock Units	−154			3,549 direct	Filing · EDGAR

34 earlier transactions are in the filing list below.

Pliant Therapeutics PLRX Director · filings 2024 to 2026

Date	Transaction	Shares	Held after	Source
Jun 11, 2026	Grant or award from the company Stock Option (Right to Buy)	+70,000	70,000 direct	Filing · EDGAR
Jun 5, 2025	Grant or award from the company Common Stock (Right to Buy)	+30,000	30,000 direct	Filing · EDGAR
Jun 13, 2024	Grant or award from the company Common Stock (Right to Buy)	+53,528	53,528 direct	Filing · EDGAR

Denali Therapeutics DNLI CFO and Treasurer · filings 2017 to 2026 · sold $15.2M · $4.3M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Jun 3, 2026	Grant or award from the company	+6,408			38,202 direct	Filing · EDGAR
Jun 3, 2026	Grant or award from the company Stock Option (right to buy)	+19,226			19,226 direct	Filing · EDGAR
Jun 3, 2025	Grant or award from the company	+6,037			31,794 direct	Filing · EDGAR
Jun 3, 2025	Grant or award from the company Stock Option (right to buy)	+18,111			18,111 direct	Filing · EDGAR
Jan 7, 2025	Open-market or private sale	−3,339	$20.81	$69K	25,757 direct	Filing · EDGAR
Dec 31, 2024	Sale under a 10b5-1 plan	−30,000	$20.25	$608K	29,096 direct	Filing · EDGAR
Sep 30, 2024	Sale under a 10b5-1 plan	−30,000	$29.03	$871K	29,096 direct	Filing · EDGAR
Aug 20, 2024	Open-market or private sale	−1,727	$23.79	$41K	32,677 direct	Filing · EDGAR
Jul 1, 2024	Sale under a 10b5-1 plan	−29,900	$22.12	$661K	34,504 direct	Filing · EDGAR
Jul 1, 2024	Sale under a 10b5-1 plan	−100	$22.80	$2K	34,404 direct	Filing · EDGAR
Jun 13, 2024	Sale under a 10b5-1 plan	−688	$21.79	$15K	52,620 direct	Filing · EDGAR
May 31, 2024	Grant or award from the company	+5,967			53,308 direct	Filing · EDGAR
May 31, 2024	Grant or award from the company Stock Option (right to buy)	+17,901			17,901 direct	Filing · EDGAR
Apr 1, 2024	Sale under a 10b5-1 plan	−92,500	$20.50	$1.9M	47,341 direct	Filing · EDGAR
Feb 13, 2024	Open-market or private sale	−2,750	$17.29	$48K	139,841 direct	Filing · EDGAR
Jan 5, 2024	Open-market or private sale	−3,208	$19.43	$62K	142,591 direct	Filing · EDGAR
Aug 21, 2023	Open-market or private sale	−1,419	$22.60	$32K	145,799 direct	Filing · EDGAR
Jun 1, 2023	Grant or award from the company	+4,216			147,218 direct	Filing · EDGAR
Jun 1, 2023	Grant or award from the company Stock Option (right to buy)	+12,649			12,649 direct	Filing · EDGAR
Feb 13, 2023	Open-market or private sale	−2,119	$30.10	$64K	143,002 direct	Filing · EDGAR
Feb 8, 2023	Open-market or private sale	−1,377	$30.88	$43K	145,121 direct	Filing · EDGAR
Jan 5, 2023	Open-market or private sale	−2,970	$28.44	$84K	146,498 direct	Filing · EDGAR
Aug 19, 2022	Open-market or private sale	−2,253	$33.22	$75K	149,468 direct	Filing · EDGAR
Jul 19, 2022	Option or RSU exercised or converted	+62,500	$0.68	$43K	151,721 direct	Filing · EDGAR
Jul 19, 2022	Option or RSU exercised or converted Stock Option (right to buy)	−62,500			0 direct	Filing · EDGAR
Feb 11, 2022	Open-market or private sale	−2,560	$34.69	$89K	120,221 direct	Filing · EDGAR
Feb 9, 2022	Open-market or private sale	−1,296	$37.09	$48K	122,781 direct	Filing · EDGAR
Jan 5, 2022	Open-market or private sale	−2,225	$44.75	$100K	124,077 direct	Filing · EDGAR
Jan 3, 2022	Grant or award from the company	+31,000			126,302 direct	Filing · EDGAR
Jan 3, 2022	Grant or award from the company Stock Option (right to buy)	+93,000			93,000 direct	Filing · EDGAR
Aug 19, 2021	Open-market or private sale	−2,085	$49.52	$103K	95,502 direct	Filing · EDGAR
Aug 19, 2021	Open-market or private sale	−200	$50.07	$10K	95,302 direct	Filing · EDGAR
Mar 15, 2021	Sale under a 10b5-1 plan	−13,258	$61.16	$811K	886,742 See footnote	Filing · EDGAR
Mar 15, 2021	Sale under a 10b5-1 plan	−32,326	$62.04	$2M	854,416 See footnote	Filing · EDGAR
Mar 15, 2021	Sale under a 10b5-1 plan	−3,258	$62.71	$204K	851,158 See footnote	Filing · EDGAR
Mar 15, 2021	Sale under a 10b5-1 plan	−1,158	$63.67	$74K	850,000 See footnote	Filing · EDGAR
Feb 16, 2021	Sale under a 10b5-1 plan	−22,684	$64.27	$1.5M	927,316 See footnote	Filing · EDGAR
Feb 16, 2021	Sale under a 10b5-1 plan	−10,199	$65.04	$663K	917,117 See footnote	Filing · EDGAR
Feb 16, 2021	Sale under a 10b5-1 plan	−16,616	$66.20	$1.1M	900,501 See footnote	Filing · EDGAR
Feb 16, 2021	Sale under a 10b5-1 plan	−501	$66.80	$33K	900,000 See footnote	Filing · EDGAR
Feb 11, 2021	Open-market or private sale	−2,635	$70.17	$185K	97,987 direct	Filing · EDGAR
Feb 11, 2021	Open-market or private sale	−400	$71.43	$29K	97,587 direct	Filing · EDGAR
Feb 9, 2021	Open-market or private sale	−1,022	$74.38	$76K	13,405 direct	Filing · EDGAR
Feb 9, 2021	Open-market or private sale	−426	$75.39	$32K	12,979 direct	Filing · EDGAR
Feb 7, 2021	Option or RSU exercised or converted	+4,250			14,427 direct	Filing · EDGAR
Feb 7, 2021	Option or RSU exercised or converted Restricted Stock Units	−4,250			8,500 direct	Filing · EDGAR
Jan 15, 2021	Sale under a 10b5-1 plan	−14,801	$70.10	$1M	985,199 See footnote	Filing · EDGAR
Jan 15, 2021	Sale under a 10b5-1 plan	−12,981	$70.96	$921K	972,218 See footnote	Filing · EDGAR
Jan 15, 2021	Sale under a 10b5-1 plan	−8,071	$71.99	$581K	964,147 See footnote	Filing · EDGAR
Jan 15, 2021	Sale under a 10b5-1 plan	−14,147	$73.01	$1M	950,000 See footnote	Filing · EDGAR
Jan 4, 2021	Grant or award from the company Restricted Stock Units	+30,000			30,000 direct	Filing · EDGAR
Jan 4, 2021	Grant or award from the company Stock Option (right to buy)	+90,000			90,000 direct	Filing · EDGAR
Aug 21, 2020	Shares withheld for tax or exercise price	−1,954	$32.87	$64K	1,006,511 See footnote	Filing · EDGAR
Aug 20, 2020	Option or RSU exercised or converted	+5,643			1,008,465 See footnote	Filing · EDGAR
Aug 20, 2020	Option or RSU exercised or converted Restricted Stock Units	−5,643			0 direct	Filing · EDGAR
Aug 18, 2020	Grant or award from the company Restricted Stock Units	+20,000			20,000 direct	Filing · EDGAR
Mar 30, 2020	Open-market or private sale	−1,428	$19.48	$28K	1,006,488 direct	Filing · EDGAR
Feb 10, 2020	Grant or award from the company Restricted Stock Units	+29,143			29,143 direct	Filing · EDGAR
Feb 10, 2020	Grant or award from the company Stock Option (right to buy)	+136,000			136,000 direct	Filing · EDGAR
Feb 7, 2020	Option or RSU exercised or converted	+4,250			1,007,916 direct	Filing · EDGAR

10 earlier transactions are in the filing list below.

Gritstone bio Director · filings 2018 to 2023

Date	Transaction	Shares	Held after	Source
Jun 16, 2023	Grant or award from the company Stock Option (Right to Buy)	+51,800	51,800 direct	Filing · EDGAR
Jun 17, 2022	Grant or award from the company Stock Option (Right to Buy)	+19,000	19,000 direct	Filing · EDGAR
Jun 18, 2021	Grant or award from the company Stock Option (Right to Buy)	+19,000	19,000 direct	Filing · EDGAR
Jun 18, 2020	Grant or award from the company Stock Option (Right to Buy)	+12,500	12,500 direct	Filing · EDGAR
Jun 19, 2019	Grant or award from the company Stock Option (Right to Buy)	+8,570	8,570 direct	Filing · EDGAR

Corvus Pharmaceuticals Director · filings 2016 to 2020

Date	Transaction	Shares	Held after	Source
Jun 9, 2020	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Mar 19, 2020	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 20, 2019	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 21, 2018	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 8, 2017	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Mar 22, 2016	Grant or award from the company Stock Option (Right to Buy)	+30,000	30,000 direct	Filing · EDGAR

All 114 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Sep 17, 2026	Form 4	Guardant Health GH	Filing · EDGAR
Sep 16, 2026	Form 144	Guardant Health GH	Filing · EDGAR
Jul 2, 2026	Form 4	Guardant Health GH	Filing · EDGAR
Jun 22, 2026	Form 4	Guardant Health GH	Filing · EDGAR
Jun 12, 2026	Form 4	Pliant Therapeutics PLRX	Filing · EDGAR
Jun 5, 2026	Form 4	Guardant Health GH	Filing · EDGAR
Jun 5, 2026	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jun 4, 2026	Form 144	Guardant Health GH	Filing · EDGAR
Jun 1, 2026	Form 4	Guardant Health GH	Filing · EDGAR
May 1, 2026	Form 4	Guardant Health GH	Filing · EDGAR
Apr 1, 2026	Form 4	Guardant Health GH	Filing · EDGAR
Mar 2, 2026	Form 4	Guardant Health GH	Filing · EDGAR
Feb 2, 2026	Form 4	Guardant Health GH	Filing · EDGAR
Jan 5, 2026	Form 4	Guardant Health GH	Filing · EDGAR
Dec 1, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Nov 3, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Oct 2, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Sep 3, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Aug 4, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Jul 2, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Jun 20, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Jun 16, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Jun 9, 2025	Form 4	Pliant Therapeutics PLRX	Filing · EDGAR
Jun 5, 2025	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jun 2, 2025	Form 4	Guardant Health GH	Filing · EDGAR
May 1, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Apr 2, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Mar 4, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Feb 4, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Jan 8, 2025	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 7, 2025	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Jan 3, 2025	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 2, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Dec 31, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Dec 2, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Nov 4, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Oct 2, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Oct 1, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Sep 30, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Sep 3, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Aug 22, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 20, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Aug 1, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Jul 3, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jul 2, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Jul 1, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Jun 17, 2024	Form 4	Pliant Therapeutics PLRX	Filing · EDGAR
Jun 17, 2024	Form 3	Pliant Therapeutics PLRX	Filing · EDGAR
Jun 13, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Jun 4, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jun 3, 2024	Form 4	Guardant Health GH	Filing · EDGAR
May 2, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Apr 2, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Apr 1, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Apr 1, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Mar 1, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Feb 15, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 13, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Feb 1, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Jan 9, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 5, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Jan 2, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Dec 4, 2023	Form 4	Guardant Health GH	Filing · EDGAR
Nov 1, 2023	Form 4	Guardant Health GH	Filing · EDGAR
Oct 2, 2023	Form 4	Guardant Health GH	Filing · EDGAR
Sep 5, 2023	Form 4	Guardant Health GH	Filing · EDGAR
Aug 23, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 21, 2023	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Aug 1, 2023	Form 4	Guardant Health GH	Filing · EDGAR
Jul 5, 2023	Form 4	Guardant Health GH	Filing · EDGAR
Jun 21, 2023	Form 4	Gritstone bio	Filing · EDGAR
Jun 16, 2023	Form 4	Guardant Health GH	Filing · EDGAR
Jun 5, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 15, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 10, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 9, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 23, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 11, 2022	Form 4	Guardant Health GH	Filing · EDGAR
Jul 21, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jul 11, 2022	Form 3	Guardant Health GH	Filing · EDGAR
Jun 22, 2022	Form 4	Gritstone bio	Filing · EDGAR
Feb 15, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 11, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 7, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 5, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Nov 19, 2021	Form 4	Gritstone bio	Filing · EDGAR
Aug 23, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Mar 16, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 18, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 16, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 11, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 20, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 6, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 24, 2020	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 20, 2020	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jun 22, 2020	Form 4	Gritstone bio	Filing · EDGAR
Jun 12, 2020	Form 4	Corvus Pharmaceuticals	Filing · EDGAR
Apr 1, 2020	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Apr 1, 2020	Form 4/A	Denali Therapeutics DNLI	Filing · EDGAR
Mar 23, 2020	Form 4	Corvus Pharmaceuticals	Filing · EDGAR
Feb 12, 2020	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 22, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jun 24, 2019	Form 4	Corvus Pharmaceuticals	Filing · EDGAR
Jun 20, 2019	Form 4	Gritstone bio	Filing · EDGAR
Feb 11, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Sep 27, 2018	Form 3	Gritstone bio	Filing · EDGAR
Aug 22, 2018	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jun 25, 2018	Form 4	Corvus Pharmaceuticals	Filing · EDGAR
Feb 28, 2018	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Dec 12, 2017	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Dec 7, 2017	Form 3	Denali Therapeutics DNLI	Filing · EDGAR
Jun 9, 2017	Form 4	Corvus Pharmaceuticals	Filing · EDGAR
Mar 24, 2016	Form 4	Corvus Pharmaceuticals	Filing · EDGAR
Mar 22, 2016	Form 3	Corvus Pharmaceuticals	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 9:39 PM ET. The filing on SEC.gov is the record.